These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 9607727)

  • 21. A G577R mutation in the human AR P box results in selective decreases in DNA binding and in partial androgen insensitivity syndrome.
    Nguyen D; Steinberg SV; Rouault E; Chagnon S; Gottlieb B; Pinsky L; Trifiro M; Mader S
    Mol Endocrinol; 2001 Oct; 15(10):1790-802. PubMed ID: 11579211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Five novel androgen receptor gene mutations associated with complete androgen insensitivity syndrome.
    Jääskeläinen J; Mongan NP; Harland S; Hughes IA
    Hum Mutat; 2006 Mar; 27(3):291. PubMed ID: 16470553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. L712V mutation in the androgen receptor gene causes complete androgen insensitivity syndrome due to severe loss of androgen function.
    Rajender S; Gupta NJ; Chakrabarty B; Singh L; Thangaraj K
    Steroids; 2013 Dec; 78(12-13):1288-92. PubMed ID: 24055831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial androgen insensitivity caused by an androgen receptor mutation at amino acid 907 (Gly-->Arg) that results in decreased ligand binding affinity and reduced androgen receptor messenger ribonucleic acid levels.
    Choong CS; Sturm MJ; Strophair JA; McCulloch RK; Tilley WD; Leedman PJ; Hurley DM
    J Clin Endocrinol Metab; 1996 Jan; 81(1):236-43. PubMed ID: 8550758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel point mutation in the hormone binding domain of the androgen receptor associated with partial and minimal androgen insensitivity syndrome.
    Galli-Tsinopoulou A; Hiort O; Schuster T; Messer G; Kuhnle U
    J Pediatr Endocrinol Metab; 2003 Feb; 16(2):149-54. PubMed ID: 12713250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of mutant androgen receptors causing partial androgen insensitivity syndrome.
    De Bellis A; Quigley CA; Marschke KB; el-Awady MK; Lane MV; Smith EP; Sar M; Wilson EM; French FS
    J Clin Endocrinol Metab; 1994 Mar; 78(3):513-22. PubMed ID: 8126121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome.
    Ahmed SF; Cheng A; Dovey L; Hawkins JR; Martin H; Rowland J; Shimura N; Tait AD; Hughes IA
    J Clin Endocrinol Metab; 2000 Feb; 85(2):658-65. PubMed ID: 10690872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular features and clinical phenotypes in androgen insensitivity syndrome in the absence and presence of androgen receptor gene mutations.
    Holterhus PM; Werner R; Hoppe U; Bassler J; Korsch E; Ranke MB; Dörr HG; Hiort O
    J Mol Med (Berl); 2005 Dec; 83(12):1005-13. PubMed ID: 16283146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bridging structural biology and genetics by computational methods: an investigation into how the R774C mutation in the AR gene can result in complete androgen insensitivity syndrome.
    Wu JH; Gottlieb B; Batist G; Sulea T; Purisima EO; Beitel LK; Trifiro M
    Hum Mutat; 2003 Dec; 22(6):465-75. PubMed ID: 14635106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in the amino-terminal domain of the human androgen receptor may be associated with partial androgen insensitivity and impaired transactivation in vitro.
    Holterhus PM; Werner R; Struve D; Hauffa BP; Schroeder C; Hiort O
    Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):457-63. PubMed ID: 16151980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complete androgen insensitivity syndrome caused by a novel mutation in the ligand-binding domain of the androgen receptor: functional characterization.
    Rosa S; Biason-Lauber A; Mongan NP; Navratil F; Schoenle EJ
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4378-82. PubMed ID: 12213902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of novel androgen receptor V770 variant in androgen insensitivity syndrome patients reveals the transitional state of the androgen receptor ligand binding domain homodimer.
    Helsen C; Rocca MS; Nguyen TT; Eerlings R; Lee XY; De Block S; Vinanzi C; Di Millo F; Giagulli V; Voet A; Ferlin A; Claessens F
    Protein Sci; 2023 Apr; 32(4):e4599. PubMed ID: 36806291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single base mutations in the human androgen receptor gene causing complete androgen insensitivity: rapid detection by a modified denaturing gradient gel electrophoresis technique.
    De Bellis A; Quigley CA; Cariello NF; el-Awady MK; Sar M; Lane MV; Wilson EM; French FS
    Mol Endocrinol; 1992 Nov; 6(11):1909-20. PubMed ID: 1480178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure of the homodimeric androgen receptor ligand-binding domain.
    Nadal M; Prekovic S; Gallastegui N; Helsen C; Abella M; Zielinska K; Gay M; Vilaseca M; Taulès M; Houtsmuller AB; van Royen ME; Claessens F; Fuentes-Prior P; Estébanez-Perpiñá E
    Nat Commun; 2017 Feb; 8():14388. PubMed ID: 28165461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathophysiology of androgen insensitivity syndromes: molecular and structural approaches of natural and engineered androgen receptor mutations at amino acid 743.
    Poujol N; Lumbroso S; Térouanne B; Lobaccaro JM; Bourguet W; Sultan C
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5793-800. PubMed ID: 12466388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel missense mutation in the amino-terminal domain of the human androgen receptor gene in a family with partial androgen insensitivity syndrome causes reduced efficiency of protein translation.
    Choong CS; Quigley CA; French FS; Wilson EM
    J Clin Invest; 1996 Sep; 98(6):1423-31. PubMed ID: 8823308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgen insensitivity syndrome due to new mutations in the DNA-binding domain of the androgen receptor.
    Imasaki K; Okabe T; Murakami H; Tanaka Y; Haji M; Takayanagi R; Nawata H
    Mol Cell Endocrinol; 1996 Jun; 120(1):15-24. PubMed ID: 8809734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human androgen receptor mutation disrupts ternary interactions between ligand, receptor domains, and the coactivator TIF2 (transcription intermediary factor 2).
    Lim J; Ghadessy FJ; Abdullah AA; Pinsky L; Trifiro M; Yong EL
    Mol Endocrinol; 2000 Aug; 14(8):1187-97. PubMed ID: 10935543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular biology of androgen insensitivity.
    Jääskeläinen J
    Mol Cell Endocrinol; 2012 Apr; 352(1-2):4-12. PubMed ID: 21871529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trafficking of androgen receptor mutants fused to green fluorescent protein: a new investigation of partial androgen insensitivity syndrome.
    Georget V; Térouanne B; Lumbroso S; Nicolas JC; Sultan C
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3597-603. PubMed ID: 9768671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.